2,710 Shares in HCA Healthcare, Inc. $HCA Acquired by Perigon Wealth Management LLC

Perigon Wealth Management LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 2,710 shares of the company’s stock, valued at approximately $1,057,000.

Several other large investors also recently added to or reduced their stakes in the business. Sumitomo Life Insurance Co. grew its position in HCA Healthcare by 1.0% during the fourth quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after buying an additional 20 shares in the last quarter. MJP Associates Inc. ADV boosted its position in shares of HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after acquiring an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC increased its position in shares of HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after purchasing an additional 21 shares during the last quarter. Anchyra Partners LLC grew its stake in HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after buying an additional 21 shares in the last quarter. Finally, Plato Investment Management Ltd raised its position in shares of HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after buying an additional 22 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the subject of several research reports. Deutsche Bank Aktiengesellschaft set a $476.00 target price on HCA Healthcare in a research note on Monday, July 27th. Oppenheimer reduced their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research report on Monday, July 27th. Argus dropped their target price on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Barclays lowered their price objective on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a report on Monday, July 27th. Finally, Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a research report on Tuesday, July 14th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $465.59.

HCA Healthcare Stock Up 1.8%

NYSE:HCA opened at $412.27 on Wednesday. The firm has a market capitalization of $89.26 billion, a P/E ratio of 13.80, a P/E/G ratio of 1.40 and a beta of 1.10. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52. The company has a fifty day moving average of $395.07 and a 200 day moving average of $445.35.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.84 earnings per share. As a group, analysts anticipate that HCA Healthcare, Inc. will post 29.47 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be issued a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.